NCT05582590 2024-01-16
Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers
NexImmune Inc.
Phase 1 Not yet recruiting
NexImmune Inc.
Mie University
M.D. Anderson Cancer Center
Mie University
PNP Therapeutics, Inc.
Herlev Hospital